T\u00fcbin\u00adgen \u2014 Health\u00adcare specia\u00adlist SHS Capi\u00adtal, toge\u00adther with its port\u00adfo\u00adlio company Medi\u00adzin\u00adtech\u00adnik Rostock GmbH (MTR), is acqui\u00adring Cura\u00adtec Services GmbH, a specia\u00adli\u00adzed provi\u00adder of medi\u00adcal elec\u00adtro\u00adsti\u00admu\u00adla\u00adtion and reha\u00adbi\u00adli\u00adta\u00adtion devices.<\/p>\n
The aim of the tran\u00adsac\u00adtion is to ensure the successful succes\u00adsion of Cura\u00adtec, to expand MTR\u2019s product port\u00adfo\u00adlio in the field of neuro\u00adlo\u00adgi\u00adcal appli\u00adca\u00adti\u00adons, func\u00adtional elec\u00adtri\u00adcal stimu\u00adla\u00adtion (FES) and incon\u00adti\u00adnence therapy and to further expand the joint market posi\u00adtion in the field of elec\u00adtri\u00adcal stimulation.<\/p>\n
Cura\u00adtec, based in North Rhine-West\u00adpha\u00adlia, has more than 25 years of expe\u00adri\u00adence in home elec\u00adtro\u00adsti\u00admu\u00adla\u00adtion therapy and has earned an excel\u00adlent repu\u00adta\u00adtion with high-quality medi\u00adcal products, a strong pati\u00adent-orien\u00adted service and estab\u00adlished rela\u00adti\u00adonships with clinics, specia\u00adlist prac\u00adti\u00adces, home\u00adcare provi\u00adders and statu\u00adtory health insu\u00adrance companies.<\/p>\n
\u201cWe are deligh\u00adted that SHS will conti\u00adnue and further expand our busi\u00adness toge\u00adther with MTR. Our grea\u00adtest concern was to ensure that the trust in the quality of our work that has been built up over many years remains intact and conti\u00adnues to bene\u00adfit the pati\u00adents who so urgen\u00adtly need our products,\u201d says Cura\u00adtec Mana\u00adging Direc\u00adtor Rainer Eckert<\/strong>.<\/p>\n \u201cBy acqui\u00adring Cura\u00adtec, we are streng\u00adthening our joint market presence and will have an even more compre\u00adhen\u00adsive product port\u00adfo\u00adlio in the field of elec\u00adtro\u00adsti\u00admu\u00adla\u00adtion therapy in future. This part\u00adner\u00adship crea\u00adtes an excel\u00adlent basis for further growth and the highest quality in pati\u00adent care,\u201d comm\u00adents MTR Mana\u00adging Direc\u00adtor Andreas Mark\u00adschies<\/strong>.<\/p>\n \u201cThis acqui\u00adsi\u00adtion exem\u00adpli\u00adfies SHS\u2019s approach of successfully leading inno\u00adva\u00adtive medi\u00adcal tech\u00adno\u00adlogy compa\u00adnies into the next gene\u00adra\u00adtion, crea\u00adting sustainable succes\u00adsion solu\u00adti\u00adons and thus secu\u00adring pati\u00adent care in the long term. We are deligh\u00adted to have found a company in Cura\u00adtec that ideally comple\u00adments MTR both in terms of its product port\u00adfo\u00adlio and its regio\u00adnal presence,\u201d explains SHS Senior Invest\u00adment Mana\u00adger Tobias Fuchs <\/strong>(photo: SHS).<\/p>\n About SHS Capital<\/strong><\/p>\n The sector inves\u00adtor SHS is a private equity provi\u00adder foun\u00added in 1993 that makes invest\u00adments in health\u00adcare compa\u00adnies in Europe. The focus of invest\u00adments is on expan\u00adsion finan\u00adcing, share\u00adhol\u00adder chan\u00adges and succes\u00adsion situa\u00adtions. \u201cBuil\u00adding Euro\u00adpean Health\u00adcare Cham\u00adpi\u00adons\u201d is the invest\u00adment philo\u00adso\u00adphy accor\u00adding to which SHS finan\u00adces and deve\u00adlops its port\u00adfo\u00adlio compa\u00adnies. The T\u00fcbin\u00adgen-based inves\u00adtor is taking both mino\u00adrity and majo\u00adrity stakes. SHS funds\u2019 natio\u00adnal and inter\u00adna\u00adtio\u00adnal inves\u00adtors include pension funds, funds of funds, foun\u00adda\u00adti\u00adons, family offices, stra\u00adte\u00adgic inves\u00adtors, entre\u00adpre\u00adneurs and the SHS manage\u00adment team. The equity or equity-like invest\u00adment of the AIF amounts to up to \u20ac 50 million. Volu\u00admes in excess of this can be reali\u00adzed with a network of co-inves\u00adtors. In its invest\u00adment decis\u00adi\u00adons, SHS places strong empha\u00adsis on the conside\u00adra\u00adtion of ESG aspects and has ther\u00ade\u00adfore commit\u00adted itself to the guide\u00adlines of the UN PRI. SHS is curr\u00adently inves\u00adt\u00ading from its sixth fund, which was laun\u00adched in 2022 and has a volume of around \u20ac 270m. \u2014 www.shs-capital.eu <\/p>\n <\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" T\u00fcbin\u00adgen \u2014 Health\u00adcare specia\u00adlist SHS Capi\u00adtal, toge\u00adther with its port\u00adfo\u00adlio company Medi\u00adzin\u00adtech\u00adnik Rostock GmbH (MTR), is acqui\u00adring Cura\u00adtec Services GmbH, a specia\u00adli\u00adzed provi\u00adder of medi\u00adcal elec\u00adtro\u00adsti\u00admu\u00adla\u00adtion and reha\u00adbi\u00adli\u00adta\u00adtion devices. The aim of the tran\u00adsac\u00adtion is to ensure the successful succes\u00adsion of Cura\u00adtec, to expand MTR\u2019s product port\u00adfo\u00adlio in the field of neuro\u00adlo\u00adgi\u00adcal appli\u00adca\u00adti\u00adons, func\u00adtional electrical [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":57335,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-57337","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\n